APA (7th ed.) Citation

M, F., A, P., C, D. G., MJ, L., N, W., P, A., . . . J, B. (2013). Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression. British journal of haematology, 163(2), 235. https://doi.org/10.1111/bjh.12491

Chicago Style (17th ed.) Citation

M, Fernandez-Mercado, et al. "Mutations in SETBP1 Are Recurrent in Myelodysplastic Syndromes and Often Coexist with Cytogenetic Markers Associated with Disease Progression." British Journal of Haematology 163, no. 2 (2013): 235. https://doi.org/10.1111/bjh.12491.

MLA (9th ed.) Citation

M, Fernandez-Mercado, et al. "Mutations in SETBP1 Are Recurrent in Myelodysplastic Syndromes and Often Coexist with Cytogenetic Markers Associated with Disease Progression." British Journal of Haematology, vol. 163, no. 2, 2013, p. 235, https://doi.org/10.1111/bjh.12491.